HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Phenotypic expansion of the supernumerary derivative (22) chromosome syndrome: VACTERL and Hirschsprung's disease.

Abstract
Phenotypically healthy carriers of the balanced 11;22 translocation, the most frequent non-Robertsonian constitutional translocation known in human beings, are at risk of having a progeny with supernumerary derivative (22)t(11;22) syndrome [der(22) syndrome]. We present the cases of 2 male patients with supernumerary der(22) syndrome [47,XY,+der(22)t(11;22)(q23;q11.2)mat], yielding partial trisomy for 22pter-q11 and 11q23-qter. These cases expand the phenotype of the der(22) syndrome, with the first case highlighting the phenotypic overlap of VACTERL and the second adding Hirschsprung's disease and intestinal malrotation to the list of associated anorectal anomalies. Because der(22) syndrome and cat eye syndrome (partial tetrasomy of 22q11) share a similar region of extra dosage on 22q11 and both typically manifest an anorectal phenotype, a dosage-sensitive gene for anorectal anomalies may be present in this locus.
AuthorsJuan C Prieto, Nilda M Garcia, Frederick F Elder, Andrew R Zinn, Linda A Baker
JournalJournal of pediatric surgery (J Pediatr Surg) Vol. 42 Issue 11 Pg. 1928-32 (Nov 2007) ISSN: 1531-5037 [Electronic] United States
PMID18022449 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
Topics
  • Abnormalities, Multiple (diagnosis, genetics)
  • Child
  • Chromosome Aberrations
  • Chromosomes, Human, Pair 22 (genetics)
  • Genetic Predisposition to Disease
  • Heterozygote
  • Hirschsprung Disease (diagnosis, genetics)
  • Humans
  • Infant
  • Male
  • Phenotype
  • Prognosis
  • Risk Assessment
  • Syndrome
  • Translocation, Genetic

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: